U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C8H6N2
Molecular Weight 130.1466
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of QUINOXALINE

SMILES

C1=CC=C2N=CC=NC2=C1

InChI

InChIKey=XSCHRSMBECNVNS-UHFFFAOYSA-N
InChI=1S/C8H6N2/c1-2-4-8-7(3-1)9-5-6-10-8/h1-6H

HIDE SMILES / InChI

Molecular Formula C8H6N2
Molecular Weight 130.1466
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Quantitative structure-activity relationships for small non-peptide antagonists of CXCR2: indirect 3D approach using the frontal polygon method.
2006-01-15
Synthesis and luminescence properties of U-shaped polycyclic molecules containing syn-facial functionalized quinoxaline rings.
2005-10-27
Investigation of the separation of heterocyclic aromatic amines by reversed phase ion-pair liquid chromatography coupled with tandem mass spectrometry: the role of ion pair reagents on LC-MS/MS sensitivity.
2005-10-25
Novel cyclophilin D inhibitors derived from quinoxaline exhibit highly inhibitory activity against rat mitochondrial swelling and Ca2+ uptake/ release.
2005-10
Efficient solid-phase-based total synthesis of the bisintercalator TANDEM.
2005-09-16
Proton driven vase-to-kite conformational change in cavitands at an air-water interface monitored by surface SHG.
2005-08-02
Synthesis of selective SRPK-1 inhibitors: novel tricyclic quinoxaline derivatives.
2005-07-01
Prediction of genotoxicity of chemical compounds by statistical learning methods.
2005-06
DNA damage induced by a quinoxaline 1,4-di-N-oxide derivative (hypoxic selective agent) in Caco-2 cells evaluated by the comet assay.
2005-05
Synthesis and characterization of p-phenylenediamine derivatives bearing an electron-acceptor unit.
2005-04-01
Replacement of active-site residues of quinoline 2-oxidoreductase involved in substrate recognition and specificity.
2005-04
Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells.
2005-04
[Studying the efficacy of a series of quinoxaline and azolo[a(b)]quinoxaline derivatives as P2X receptor antagonists].
2005-03-25
Iridium(III) complexes with orthometalated quinoxaline ligands: subtle tuning of emission to the saturated red color.
2005-03-07
Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP-ribose) polymerase-1/2 inhibitors.
2005-02-28
Part 3: synthesis and biological evaluation of some analogs of the antitumor agents, 2-{4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy}propionic acid, and 2-{4-[(7-bromo-2-quinolinyl)oxy]phenoxy}propionic acid.
2005-02-15
Functional cross-talk between fatty acid synthesis and nonribosomal peptide synthesis in quinoxaline antibiotic-producing streptomycetes.
2005-02-11
Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.
2005-02-10
[New methyl-quinoxaline derivatives with antimicrobial activity].
2005-02-04
In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria.
2005-02
Water-soluble benzoheterocycle triosmium clusters as potential inhibitors of telomerase enzyme.
2005-02
On the microscopic theory of polar solvation dynamics.
2005-01-22
Reactivity and transformation of antibacterial N-oxides in the presence of manganese oxide.
2005-01-15
Quinoxaline 1,4-dioxide: a versatile scaffold endowed with manifold activities.
2005
Selective toxicity of a quinoxaline 1,4-di-N-oxide derivative in human tumour cell lines.
2005
Immunochemical detection of 3-deoxyglucosone in serum.
2004-12-17
Lewis acid-promoted annulation of O-quinonediimines by allylstannane: a facile synthesis of quinoxaline derivatives.
2004-12-09
Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.
2004-10-01
The effect of oxythioquinox exposure on normal human mammary epithelial cell gene expression: a microarray analysis study.
2004-09-23
Hypoxic cells in tumors as a target for cancer therapy.
2004-08-10
A new family of quinoline and quinoxaline analogues of combretastatins.
2004-07-16
Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada.
2004-07-01
The influence of intercalator binding on DNA triplex stability: correlation with effects on A-tract duplex structure.
2004-07-01
Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.
2004-07-01
Zn(II)-induced conformational control of amphiphilic cavitands in langmuir monolayers.
2004-06-21
Solution-phase synthesis of nucleobase-substituted analogues of triostin A.
2004-05-28
Lead discovery of quinoxalinediones as an inhibitor of dipeptidyl peptidase-IV (DPP-IV) by high-throughput screening.
2004-05-17
Co-targeting IGF-1R and c-kit: synergistic inhibition of proliferation and induction of apoptosis in H 209 small cell lung cancer cells.
2004-05-04
Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.
2004-05
Thermodynamic properties of quinoxaline-1,4-dioxide derivatives: a combined experimental and computational study.
2004-04-16
[How have we found any new reactions in the field of the heterocyclic chemistry?].
2004-04
Design and synthesis of novel imidazo[1,2-a]quinoxalines as PDE4 inhibitors.
2004-03-01
Quinoxaline chemistry. Part XVII. Methyl [4-(substituted 2-quinoxalinyloxy) phenyl] acetates and ethyl N-([4-(substituted 2-quinoxalinyloxy) phenyl] acetyl) glutamates analogs of methotrexate: synthesis and evaluation of in vitro anticancer activity.
2004-03
Successive determination of thiamine and ascorbic acid in pharmaceuticals by flow injection analysis.
2004-02-18
Quinoxaline excision: a novel approach to tri- and diquinoxaline cavitands.
2004-02-05
Metal-assisted light-induced DNA cleavage activity of 2-(methylthio)phenylsalicylaldimine Schiff base copper(II) complexes having planar heterocyclic bases.
2004-02
Synthesis and Bergman cyclization of a beta-extended porphyrenediyne.
2004-01-21
Synthesis and biological activity of new quinoxaline antibiotics of echinomycin analogues.
2004-01-19
Photophysical processes in quinoxaline vapor at low pressure.
2003-11
Metal-assisted red light-induced efficient DNA cleavage by dipyridoquinoxaline-copper(II) complex.
2003-10-07
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:18:25 GMT 2025
Edited
by admin
on Mon Mar 31 19:18:25 GMT 2025
Record UNII
QM4AR6M6T8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
QUINOXALINE
MI  
Systematic Name English
QUINOXALINE [MI]
Preferred Name English
Code System Code Type Description
WIKIPEDIA
QUINOXALINE
Created by admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
PRIMARY
MERCK INDEX
m9465
Created by admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID6049432
Created by admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
PRIMARY
ECHA (EC/EINECS)
202-047-4
Created by admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
PRIMARY
FDA UNII
QM4AR6M6T8
Created by admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
PRIMARY
CAS
91-19-0
Created by admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
PRIMARY
PUBCHEM
7045
Created by admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
PRIMARY
CHEBI
36616
Created by admin on Mon Mar 31 19:18:25 GMT 2025 , Edited by admin on Mon Mar 31 19:18:25 GMT 2025
PRIMARY